facebook

What to Expect From YAG Laser Capsulotomy at Blue Fin Vision®

YAG laser capsulotomy is the standard treatment for posterior capsular opacification, the gradual clouding of the membrane behind the intraocular lens that can develop months or years after cataract surgery. ¹ At Blue Fin Vision®, the procedure is performed in clinic and requires no theatre admission.

Before the procedure, dilating drops are instilled to widen the pupil and improve access to the posterior capsule. A contact lens is placed gently on the eye to stabilise it and focus the laser beam. The laser delivers a series of precisely targeted pulses to create a small, clear opening in the clouded capsule. The procedure takes approximately five to ten minutes and is not uncomfortable. ³

Patients typically notice an immediate improvement in visual clarity, though some experience floaters in the days following treatment as small fragments of capsule disperse within the vitreous. ² These usually settle without intervention. A brief postoperative review confirms that the capsulotomy is adequately sized and that intraocular pressure remains within the normal range.

YAG capsulotomy is a permanent treatment. Once the opening is created, posterior capsular opacification does not recur at that site. ¹ The visual clarity achieved following the procedure is stable and long-lasting in the great majority of patients.

References

1. Kohnen T, Bühren J, Klaproth OK, Kook D. Posterior capsule opacification: pathophysiology and prevention. Progress in Retinal and Eye Research. 2019;68:1–19.

2. Billotte C, Berdeaux G. Adverse clinical consequences of neodymium:YAG laser treatment of posterior capsule opacification. Journal of Cataract and Refractive Surgery. 2004;30(10):2064–2071.

3. Aslam TM, Devlin H, Dhillon B. Use of Nd:YAG laser capsulotomy. Survey of Ophthalmology. 2003;48(6):594–612.

Related Topics:

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.